Journal of Oral and Maxillofacial Surgery
Volume 64, Issue 9 , Pages 1409-1414, September 2006

Surgical Salvage for Local and Regional Recurrence in Oral Cancer

  • Robert A. Ord, DDS, MD, FRCS, MS

      Affiliations

    • Professor/Chairman, Department of Oral and Maxillofacial Surgery, University of Maryland, Greenbaum Cancer Center, Baltimore, MD.
  • ,
  • Antonia Kolokythas, DDS

      Affiliations

    • Maxillofacial Oncology Fellow, Department of Oral and Maxillofacial Surgery, University of Maryland, Baltimore, MD.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Kolokythas: Department of Oral and Maxillofacial Surgery, University of Maryland, 419 West Redwood Street, Suite 410, Baltimore, MD 21201-1754
  • ,
  • Mark A. Reynolds, DDS, PhD

      Affiliations

    • Chairman, Department of Periodontology, Baltimore College of Dental Surgery, Baltimore, MD.

Purpose

To evaluate local and regional recurrence and the outcomes for salvage surgery in patients for oral cancer.

Patients and Methods

This study analyzed 354 consecutive patients with oral cancer treated primarily by surgery or surgery combined with adjuvant therapy by 1 surgeon (R.A.O.) between February 1991 and September 2001.

Results

Overall recurrence rate was 15.5%; with 5.4% local, 8.5% regional, and 1.4% locoregional. Overall salvage for local recurrence was 52.6% 3-year survival, and statistically significant favorable prognostic factors were salvaged by surgery alone and initial cancer staging of I/II. Overall salvage for regional recurrence was 50%, with recurrence in a previously untreated neck and salvage with radical neck dissection plus radiotherapy giving the best prognosis. No patients with locoregional recurrence were salvaged.

Conclusions

Patients who were stage I/II and were treated initially by surgery alone were the best candidates for salvage if they recurred. Salvage was best achieved with surgery or surgery + adjuvant therapy, and patients recurring within 6 months had a worse survival. Patients with locoregional recurrence or treated with RT ± chemotherapy alone have negligible survival.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0278-2391(06)00689-6

doi:10.1016/j.joms.2006.05.026

Journal of Oral and Maxillofacial Surgery
Volume 64, Issue 9 , Pages 1409-1414, September 2006